Abbott has received clearance from the U.S. Food and Drug Administration (FDA) for two new over-the-counter continuous glucose monitoring (CGM) systems. This approval allows these CGM systems to be sold without a prescription, making them more accessible to consumers. The announcement was made on Monday by Abbott, and it marks a significant step in the availability of diabetes management tools.
#US FDA clears #Abbott's continuous glucose monitors for over-the-counter use
US FDA clears Abbott's continuous glucose monitors for over-the-counter use https://t.co/IfO1Oz0Tb1 https://t.co/Zgx6XtnIxy
Abbott said on Monday that the U.S. Food and Drug Administration has cleared its two continuous glucose monitoring systems for over-the-counter use. https://t.co/tsnFMzdoIp https://t.co/tsnFMzdoIp
Abbott Receives U.S. FDA Clearance For Two New Over-The-Counter Continuous Glucose Monitoring Systems (Full Statement) https://t.co/As65vRy1rF https://t.co/B9pju6OZUB
Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems $ABT https://t.co/3MVULdhYRn
Happy to hear that cgm will be available otc. https://t.co/21rxcJ4Mam via @jareddashevsky